Buy or sell Transcriptic stock pre IPO via an EquityZen fund
Transcriptic is a SaaS-based biotechnology company providing robotic solutions for biology labs.
About Transcriptic Stock
Transcriptic is a new kind of scientific outsourcing provider. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Transcriptic was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. Molecular cloning is just the beginning. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.
Head of Scientific Operations
Head of Sales
VP of Engineering, Hardware
Founder & Chief Executive Officer
VP Engineering, Software
Business Wire (press release) - May, 10 2018
GenomeWeb - Apr, 12 2018
Forbes - Dec, 21 2017